CAMBRIDGE, Mass.--(BUSINESS WIRE)--Feb. 14, 2012--
Pharmaceuticals, Inc. (NASDAQ: ARIA) today announced that it will
host a live webcast of its quarterly conference call at 8:30 a.m. (ET)
on Tuesday, February 28, 2012. Harvey J. Berger, M.D., chairman and
chief executive officer, will host the call. Senior management will
discuss the Company’s financial results as of December 31, 2011, key
corporate objectives and additional corporate activities. The Company
will announce the highlights of these topics in a press release to be
issued before the market opens on February 28, 2012 prior to the
The live webcast can be accessed by visiting the investor relations
section of the Company’s website at http://investor.ariad.com.
The call can be accessed by dialing 866-700-0133 (domestic) or
617-213-8831 (international) five minutes prior to the start time and
providing the pass code 24601830. A replay of the call will be available
on the ARIAD website approximately two hours after completion of the
call and will be archived for three weeks.
ARIAD Pharmaceuticals, Inc. is an emerging global oncology company
focused on the discovery, development and commercialization of medicines
to transform the lives of cancer patients. ARIAD’s approach to
structure-based drug design has led to three internally discovered,
molecularly targeted product candidates for drug-resistant and
difficult-to-treat cancers, including certain forms of chronic myeloid
leukemia, soft tissue and bone sarcomas and non-small cell lung cancer.
For additional information, visit http://www.ariad.com.
Source: ARIAD Pharmaceuticals, Inc.
ARIAD Pharmaceuticals, Inc.
Liza Heapes, 617-621-2315